0044649309360

GLUNEM-C

AI Insights

The barcode 0044649309360 is associated with the product GLUNEM-C, which is a medication used to treat multiple sclerosis (MS). GLUNEM-C contains glatiramer acetate, a synthetic protein that mimics myelin basic protein. It works by modulating immune processes that are thought to be involved in the pathogenesis of MS, ultimately helping to slow the progression of the disease and reduce the frequency of relapses.

As with any prescription medication, there are important considerations and potential warnings:

  1. Contraindications: GLUNEM-C may not be suitable for individuals with certain medical conditions or those who are allergic to its components. It is crucial to disclose your full medical history to your healthcare provider before starting treatment.

  2. Side Effects: Common side effects can include injection site reactions, flushing, rapid heart rate, and chest pain. In some cases, more serious side effects such as allergic reactions could occur.

  3. Monitoring: Patients may be advised to monitor their health closely while on this medication and report any unusual symptoms to their healthcare provider immediately.

  4. Drug Interactions: Individuals taking other medications should discuss potential interactions with their healthcare provider to ensure safe use.

As for pricing and specific product details, this information can vary significantly based on location, insurance coverage, and pharmacy. It is advisable to consult a healthcare professional or a pharmacy for current pricing and availability.

Lastly, due to the nature of GLUNEM-C as a prescription medication, obtaining it requires a doctor's guidance and approval. If you have further questions or need assistance related to this medication, consulting a healthcare professional is the best approach.

バーコード詳細
出典: USA
製造者コード: 4649
製品コード: 30936
検索統計
今日:
0
先週:
6
先月:
32
総検索数:
109

コメント 0

まだコメントはありません。最初のコメントを投稿しましょう!

顧客満足度

この製品情報は役に立ちましたか?

0 / 0

この製品をおすすめしますか?

0 / 0
上位 10 か国
Vietnam 2
United States 35
United Kingdom 3
Singapore 9
Russia 2
Indonesia 1
Hong Kong 4
Germany 6
France 11
Finland 7
Ethiopia 1
China 3
Canada 7